Tiziana Life Sciences Ltd
TLSA- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001723069
In the last 90 days, Tiziana Life Sciences Ltd insiders filed 4 open-market purchases and 0 sales; 30 institutions reported holding it in 13F filings for Q2 2026, worth $3.10M in total; no superinvestor holds it.
13F holders, Q2 2021
Institutional positions in Tiziana Life Sciences Ltd as of Jun 30, 2021. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 23
- 0 vs. Q1 2021
- Shares held
- 5.57M
- +472.2K (+9.3%) vs. Q1 2021
- Total value
- $13.1M
- −$1.07M (−7.5%) vs. Q1 2021
- New holders
- 4
- 7 more added
- Sold out
- 4
- 6 more reduced
Compare with Q1 2021: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting TLSA on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 30 | $3.10M |
| Q1 2026 | 32 | $3.67M |
| Q4 2025 | 33 | $3.05M |
| Q3 2025 | 31 | $8.72M |
| Q2 2025 | 30 | $4.04M |
| Q1 2025 | 32 | $3.25M |
| Q4 2024 | 33 | $698.3K |
| Q3 2024 | 30 | $1.78M |
| Q2 2024 | 26 | $1.16M |
| Q1 2024 | 20 | $373.7K |
| Q4 2023 | 21 | $443.4K |
| Q3 2023 | 24 | $521.9K |
| Q2 2023 | 20 | $596.8K |
| Q1 2023 | 18 | $1.15M |
| Q4 2022 | 23 | $3.17M |
| Q3 2022 | 25 | $4.15M |
| Q2 2022 | 24 | $3.97M |
| Q1 2022 | 23 | $6.02M |
| Q4 2021 | 23 | $5.63M |
| Q3 2021 | 23 | $2.04M |
| Q2 2021 | 23 | $13.1M |
| Q1 2021 | 23 | $14.1M |
Institutions, Q2 2021
Shares, value and share of portfolio for each institution holding Tiziana Life Sciences Ltd; share changes are against Q1 2021.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| HighTower Advisors, LLC | 4,042,984 | $9.48M | 0.03% | −8,100−0.2% | Reduced |
| BlackRock Inc. | 560,460 | $1.31M | 0.00% | +560,460 | New |
| Morgan Stanley | 281,617 | $660.0K | 0.00% | −16,246−5.5% | Reduced |
| State Street Corp | 211,438 | $496.0K | 0.00% | +4,280+2.1% | Added |
| Marshall Wace, LLP | 114,388 | $268.0K | 0.00% | −72,083−38.7% | Reduced |
| Geode Capital Management, LLC | 84,581 | $198.0K | 0.00% | +69,729+469.5% | Added |
| Renaissance Technologies LLC | 65,340 | $153.0K | 0.00% | +17,193+35.7% | Added |
| Orion Portfolio Solutions, LLC | 49,998 | $117.0K | 0.00% | +7,112+16.6% | Added |
| Ausdal Financial Partners, Inc. | 39,900 | $94.0K | 0.01% | 00.0% | Unchanged |
| Capital Asset Advisory Services LLC | 37,834 | $89.0K | 0.01% | 00.0% | Unchanged |
| Bank of America Corp | 34,130 | $80.0K | 0.00% | +7,221+26.8% | Added |
| D. E. Shaw & Co., Inc. | 16,751 | $39.0K | 0.00% | +16,751 | New |
| Susquehanna International Group, LLP | 11,627 | $27.0K | 0.00% | −9,912−46.0% | Reduced |
| Platform Technology Partners | 10,000 | $23.0K | 0.01% | +10,000 | New |
| IFP Advisors, Inc | 5,400 | $12.0K | 0.00% | +1,482+37.8% | Added |
| Group One Trading, L.P. | 3,798 | $9.00K | 0.00% | +3,500+1,174.5% | Added |
| UBS Group AG | 1,278 | $3.00K | 0.00% | +1,278 | New |
| Spire Wealth Management | 750 | $2.00K | 0.00% | −10,000−93.0% | Reduced |
| Cutler Group LP | 500 | $1.00K | 0.00% | 00.0% | Unchanged |
| Tradewinds Capital Management, LLC | 250 | $1.00K | 0.00% | 00.0% | Unchanged |
| Simplex Trading, LLC | 363 | $0 | 0.00% | −8,101−95.7% | Reduced |
| Barclays PLC | 191 | $0 | 0.00% | 00.0% | Unchanged |
| Cypress Capital Management LLC (WY) | 5 | $0 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 0 | $0 | 0.00% | −35,850−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −34,687−100.0% | Sold out |
| Legal & General Group Plc | 0 | $0 | 0.00% | −21,530−100.0% | Sold out |
| QCM Cayman, Ltd. | 0 | $0 | 0.00% | −10,298−100.0% | Sold out |